OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis
Enrica Federti, Alessandro Mattè, Veronica Riccardi, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 76-76
Open Access | Times Cited: 8
Enrica Federti, Alessandro Mattè, Veronica Riccardi, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 76-76
Open Access | Times Cited: 8
Showing 8 citing articles:
Haemochromatosis
Paul C. Adams, Gary P. Jeffrey, John Ryan
The Lancet (2023) Vol. 401, Iss. 10390, pp. 1811-1821
Closed Access | Times Cited: 53
Paul C. Adams, Gary P. Jeffrey, John Ryan
The Lancet (2023) Vol. 401, Iss. 10390, pp. 1811-1821
Closed Access | Times Cited: 53
Redox signaling and metabolism in Alzheimer's disease
Mariana Holubiec, Manuela Gellert, Eva-Maria Hanschmann
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 39
Mariana Holubiec, Manuela Gellert, Eva-Maria Hanschmann
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 39
Endothelial USP11 drives VEGFR2 signaling and angiogenesis via PRDX2/c-MYC axis
Can Chen, Zilong Chen, Ruijie Luo, et al.
Angiogenesis (2025) Vol. 28, Iss. 2
Closed Access
Can Chen, Zilong Chen, Ruijie Luo, et al.
Angiogenesis (2025) Vol. 28, Iss. 2
Closed Access
FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
Austin Lui, Jordan Vanleuven, David Perekopskiy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1546-1546
Open Access | Times Cited: 16
Austin Lui, Jordan Vanleuven, David Perekopskiy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1546-1546
Open Access | Times Cited: 16
Yeast as a Model to Find New Drugs and Drug Targets for VPS13-Dependent Neurodegenerative Diseases
Joanna Kamińska, Piotr Soczewka, Weronika Rzepnikowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5106-5106
Open Access | Times Cited: 15
Joanna Kamińska, Piotr Soczewka, Weronika Rzepnikowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5106-5106
Open Access | Times Cited: 15
Theaflavin-3,3′-digallate ameliorates learning and memory impairments in mice with premature brain aging induced by D-galactose
Yichou Cao, Yunyi Zhang, Zehan Jia, et al.
Physiology & Behavior (2023) Vol. 261, pp. 114077-114077
Closed Access | Times Cited: 8
Yichou Cao, Yunyi Zhang, Zehan Jia, et al.
Physiology & Behavior (2023) Vol. 261, pp. 114077-114077
Closed Access | Times Cited: 8
Pegylated polymeric micelles of boswellic acid-selenium mitigates repetitive mild traumatic brain injury: Regulation of miR-155 and miR-146a/BDNF/ Klotho/Foxo3a cue
Amira A. El-Gazar, Soad Z. El‐Emam, Shorouk M. El-Sayyad, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112118-112118
Closed Access | Times Cited: 1
Amira A. El-Gazar, Soad Z. El‐Emam, Shorouk M. El-Sayyad, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112118-112118
Closed Access | Times Cited: 1
Exploring the pathophysiological mechanisms and wet biomarkers of VPS13A disease
Jian Lin, Hongmei Meng, Nilupaer Shafeng, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
Jian Lin, Hongmei Meng, Nilupaer Shafeng, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
